AU
CA
NZ
UK
US
IND
Kalkine has a fully transformed New Avatar.
Last update at 2026-03-10T16:35:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
3 UK Stocks Estimated To Be Trading Below Intrinsic Value By At Least 13.5%
Mon 07 Jul 25, 06:37 AM3 UK Growth Companies With High Insider Ownership And 20% Revenue Growth
Wed 07 May 25, 06:36 AMUK Stocks That Might Be Trading Below Their Estimated Value
Wed 16 Apr 25, 06:37 AM3 UK Stocks Estimated To Trade At Discounts Of Up To 40.8%
Thu 10 Apr 25, 06:37 AM3 UK Stocks That May Be Priced Below Estimated Value In April 2025
Tue 08 Apr 25, 06:07 AMUK Stocks That May Be Trading Below Their Estimated Value
Thu 27 Mar 25, 06:07 AMUK Growth Companies With High Insider Ownership
Thu 01 Aug 24, 03:33 PM| Breakdown | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
| Income before tax | 28.50M | 24.38M | 17.93M | 9.88M |
| Minority interest | - | - | - | - |
| Net income | 21.10M | 18.65M | 13.82M | 8.21M |
| Selling general administrative | - | 17.55M | 9.24M | 4.13M |
| Selling and marketing expenses | - | - | - | - |
| Gross profit | 48.20M | 40.38M | 26.51M | 13.61M |
| Reconciled depreciation | - | 0.91M | 0.63M | 0.47M |
| Ebit | 28.60M | 24.47M | 17.98M | 9.95M |
| Ebitda | 29.70M | 25.38M | 18.61M | 10.42M |
| Depreciation and amortization | 1.10M | 0.91M | 0.63M | 0.47M |
| Non operating income net other | - | - | - | - |
| Operating income | 29.80M | 24.92M | 17.91M | 9.95M |
| Other operating expenses | 77.30M | 61.23M | 42.87M | 25.08M |
| Interest expense | 0.10M | 0.09M | 0.05M | 0.07M |
| Tax provision | - | 5.73M | 4.11M | 1.67M |
| Interest income | - | 0.73M | 0.07M | 0.00000M |
| Net interest income | - | 0.65M | 0.02M | -0.06500M |
| Extraordinary items | - | - | - | - |
| Non recurring | - | - | - | - |
| Other items | - | - | - | - |
| Income tax expense | 7.40M | 5.73M | 4.11M | 1.67M |
| Total revenue | 107.10M | 86.15M | 60.78M | 35.03M |
| Total operating expenses | 18.40M | 15.47M | 9.24M | 4.13M |
| Cost of revenue | 58.90M | 45.77M | 34.27M | 21.42M |
| Total other income expense net | -1.30000M | -0.53300M | 0.02M | -0.06500M |
| Discontinued operations | - | - | - | - |
| Net income from continuing ops | - | 18.65M | 13.82M | 8.21M |
| Net income applicable to common shares | - | - | - | - |
| Preferred stock and other adjustments | - | - | - | - |
| Breakdown | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
| Total assets | 75.00M | 59.65M | 40.62M | 22.11M |
| Intangible assets | 0.10M | 0.04M | 0.04M | 0.00100M |
| Earning assets | - | - | - | - |
| Other current assets | 1.70M | 1.09M | 0.44M | 0.20M |
| Total liab | 20.70M | 11.63M | 11.87M | 7.24M |
| Total stockholder equity | 54.30M | 48.02M | 28.75M | 14.87M |
| Deferred long term liab | - | - | - | - |
| Other current liab | 6.30M | 4.76M | 2.91M | 1.96M |
| Common stock | 0.10M | - | - | - |
| Capital stock | - | 0.00000M | 0.00000M | 0.00000M |
| Retained earnings | 53.80M | 47.78M | 28.69M | 14.87M |
| Other liab | - | - | - | - |
| Good will | - | - | - | - |
| Other assets | - | - | - | - |
| Cash | 18.50M | 18.72M | 12.73M | 5.40M |
| Cash and equivalents | - | - | - | - |
| Total current liabilities | 17.70M | 9.90M | 9.54M | 5.85M |
| Current deferred revenue | 0.20M | - | - | - |
| Net debt | -15.50000M | -16.91700M | -10.67300M | -4.27100M |
| Short term debt | 0.60M | 0.63M | 0.26M | 0.13M |
| Short long term debt | - | 0.00000M | 0.00100M | 0.00800M |
| Short long term debt total | 3.00M | 1.80M | 2.06M | 1.13M |
| Other stockholder equity | - | - | - | - |
| Property plant equipment | - | - | - | - |
| Total current assets | 68.70M | 55.54M | 37.21M | 20.16M |
| Long term investments | - | - | - | - |
| Net tangible assets | - | - | - | - |
| Short term investments | - | - | - | - |
| Net receivables | 25.70M | 16.25M | 11.07M | 5.86M |
| Long term debt | - | - | - | - |
| Inventory | 22.80M | 19.48M | 12.97M | 8.70M |
| Accounts payable | 10.60M | 3.77M | 2.58M | 2.44M |
| Total permanent equity | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - |
| Accumulated other comprehensive income | 0.40M | 0.24M | 0.06M | - |
| Additional paid in capital | - | - | - | - |
| Common stock total equity | - | - | - | - |
| Preferred stock total equity | - | - | - | - |
| Retained earnings total equity | - | - | - | - |
| Treasury stock | - | - | - | - |
| Accumulated amortization | - | - | - | - |
| Non currrent assets other | - | 0.00100M | - | - |
| Deferred long term asset charges | - | - | - | - |
| Non current assets total | 6.30M | 4.12M | 3.40M | 1.95M |
| Capital lease obligations | - | 1.80M | 2.06M | 1.12M |
| Long term debt total | - | - | - | - |
| Breakdown | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
| Investments | - | - | - | - |
| Change to liabilities | - | - | - | - |
| Total cashflows from investing activities | -1.00000M | -0.40700M | -0.98900M | -0.26700M |
| Net borrowings | - | -0.00100M | -0.00700M | -2.81400M |
| Total cash from financing activities | -15.10000M | -0.33900M | -0.21700M | -8.97900M |
| Change to operating activities | - | - | - | - |
| Net income | 21.10M | 24.38M | 17.93M | 9.88M |
| Change in cash | -0.22000M | 5.99M | 7.34M | 5.40M |
| Begin period cash flow | 18.72M | 12.73M | 5.40M | 8.15M |
| End period cash flow | 18.50M | 18.72M | 12.73M | 5.40M |
| Total cash from operating activities | 16.20M | 6.70M | 8.59M | 6.49M |
| Issuance of capital stock | - | - | - | - |
| Depreciation | 1.10M | 0.91M | 0.63M | 0.47M |
| Other cashflows from investing activities | - | 0.61M | - | -0.00100M |
| Dividends paid | 14.70M | - | - | 6.00M |
| Change to inventory | -3.40000M | -6.50700M | -4.27500M | -3.74900M |
| Change to account receivables | -10.90000M | -5.99300M | -5.45100M | -0.30100M |
| Sale purchase of stock | - | - | - | - |
| Other cashflows from financing activities | -0.40000M | -0.33800M | -0.21000M | -0.16300M |
| Change to netincome | - | - | - | - |
| Capital expenditures | 1.00M | 1.04M | 0.96M | 0.29M |
| Change receivables | - | - | - | - |
| Cash flows other operating | - | - | - | - |
| Exchange rate changes | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - |
| Change in working capital | -7.30000M | -8.35700M | -8.08100M | -2.52100M |
| Stock based compensation | - | 0.17M | 0.00000M | 0.00000M |
| Other non cash items | 1.30M | -10.40100M | -1.89200M | -1.33900M |
| Free cash flow | 15.20M | 6.28M | 7.62M | 6.20M |
Sector: Consumer Defensive Industry: Packaged Foods
| Company | Change (GBX) | Price (GBX) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| APN Applied Nutrition Plc |
- -% | 237.50 | 29.84 | 21.64 | 5.57 | 11.28 | 5.57 | 20.10 |
| ABF Associated British Foods PLC |
- -% | 1846.50 | 13.57 | 12.18 | 0.70 | 1.22 | 0.83 | 6.06 |
| TATE Tate & Lyle PLC |
- -% | 349.20 | 15.58 | 11.52 | 1.50 | 2.15 | 1.62 | 8.42 |
| CWK Cranswick PLC |
- -% | 5210.00 | 16.56 | 15.95 | 0.87 | 2.34 | 0.86 | 8.45 |
| PFD Premier Foods PLC |
- -% | 190.20 | 12.38 | 10.37 | 1.09 | 0.88 | 1.34 | 7.35 |
Applied Nutrition Plc engages in the manufacture, wholesale, and retail of sports nutritional products in the United Kingdom and internationally. It offers whey protein, whey protein isolate, casein protein powder, clear protein, vegan protein, protein bars and oats, protein shakes and cans, and beef protein; BCAA powders and tablets, BCAA cans, creatine, aminos, and energy gels and drinks; pre-workout drinks, powders, and gels; and hydration and vitamin water, hydration tablets, hydration electrolyte and vitamin powder, and energy shots, as well as caffeine capsules and mass gainers. The company also provides products for liver support, health and vitality, vitality range, collagen, vitamins, and cooking; and gym clothing and bags, bottles and shakers, and funnels and scoops, as well as digital watches. It provides its products under the Applied Nutrition, ABE All Black Everything, BodyFuel, and Endurance brands. Applied Nutrition Plc was incorporated in 2014 and is based in Liverpool, United Kingdom.
2 Acornfield Road, Liverpool, United Kingdom, L33 7UG
| Name | Title | Year Born |
|---|---|---|
| Mr. Thomas Michael Ryder | Founder, CEO & Director | 1983 |
| Mr. Joseph Pollard | CFO & Director | 1988 |
| Mr. Steven Granite | COO & Director | 1979 |
| Mr. Aaron Heidebreicht | CEO of Applied Nutrition USA | 1986 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...